Clinical and dosimetric considerations for Y90: recommendations from an international multidisciplinary working group

Overview of attention for article published in European Journal of Nuclear Medicine and Molecular Imaging, May 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#16 of 5,143)
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 17 news outlets
policy: 2 policy sources

twitter: 3 X users
guideline: 2 clinical guideline sources

Readers on

mendeley: 123 Mendeley

So far, Altmetric has seen 23 news stories from 17 outlets.

International Multidisciplinary Group Publishes Recommendations for Personalized HCC ...

Medical Health News, 01 Aug 2019

— New consensus recommendations for personalized treatment for hepatocellular carcinoma (HCC) with BTG’s TheraSphere have been…

Recommendations for Personalised HCC Treatment With Y90 TheraSphere™ Published by an ...

Medical Health News, 23 Jul 2019

/PRNewswire/ -- BTG plc (LSE: BTG), a global healthcare company, today announced consensus recommendations for personalised…

Recommendations for Personalised HCC Treatment With Y90 TheraSphere™ Published by an International Multidisciplinary Group

BioTech Gate, 23 Jul 2019

Supported by comparative Dosisphere data, a phase II multicentric randomised dosimetry trial LONDON, July 23, 2019 /PRNewswire/ …

News story from Finanz Nachrichten on Tuesday 23 July 2019

Finanz Nachrichten, 23 Jul 2019

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 19 additional news stories.